K921939 is an FDA 510(k) clearance for the SERALYZER(R) THERAPEUTIC DRUG ASSAY CONTROL(ABNOR). Classified as Drug Specific Control Materials (product code LAS), Class I - General Controls.
Submitted by Heraeus Kulzer, Inc. (Mishawaka, US). The FDA issued a Cleared decision on July 16, 1992 after a review of 83 days - a notably fast clearance cycle.
This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3280 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Heraeus Kulzer, Inc. devices